-transparent.png){kind=logo}
T-cell subsets were studied by flow cytometry in 58 feline leukaemia virus (FeLV)-positive cats with naturally acquired FeLV infection to determine whether the changes in CD4+ or CD8+ T cell populations differed from those observed in 55 feline immunodeficiency virus (FIV)-positive cats with naturally acquired FIV infection. The sole criterion for inclusion into the study was seropositivity. Mean (SD) CD4+ T cell values of FeLV positive cats were decreased to 31.1 (8.0) per cent and their CD8+ T cell values were increased to 22.8 (6.3) per cent in comparison with uninfected control cats (37.9 [9.5] per cent CD4+; 15.2 [6.3] per cent CD8+). The CD4+/CD8+ ratio was reduced to 1.5 (0.7), compared with 3.0 (1.5) in 39 FeLV-and FIV-negative control cats. Differences from control values were significant, but there was no significant difference between CD4+ and CD8+ lymphocytes of FeLV-versus FIV-infected cats. These findings indicate that FeLV and FIV have similar effects on T lymphocyte subsets. Both retrovirus infections can induce immunodeficiency, both viruses infect a broad range of lymphohaemopoietic cells, despite having different primary target cells, and can induce the killing of lymphocytic cells in vitro. It is concluded that a decreased CD4+/CD8+ ratio is not restricted to FIV infections but may also occur in FeLV infection.
G Hoffmann-Fezer, and
W Mortelbauer, and
K Hartmann, and
J Mysliwietz, and
S Thefeld, and
B Beer, and
I Thum, and
W Kraft
August 1994,
New Zealand veterinary journal,
G Hoffmann-Fezer, and
W Mortelbauer, and
K Hartmann, and
J Mysliwietz, and
S Thefeld, and
B Beer, and
I Thum, and
W Kraft
March 2004,
Microbes and infection,
G Hoffmann-Fezer, and
W Mortelbauer, and
K Hartmann, and
J Mysliwietz, and
S Thefeld, and
B Beer, and
I Thum, and
W Kraft
September 1977,
Nature,
G Hoffmann-Fezer, and
W Mortelbauer, and
K Hartmann, and
J Mysliwietz, and
S Thefeld, and
B Beer, and
I Thum, and
W Kraft
December 1990,
AIDS (London, England),
G Hoffmann-Fezer, and
W Mortelbauer, and
K Hartmann, and
J Mysliwietz, and
S Thefeld, and
B Beer, and
I Thum, and
W Kraft
January 2013,
Journal of veterinary internal medicine,
G Hoffmann-Fezer, and
W Mortelbauer, and
K Hartmann, and
J Mysliwietz, and
S Thefeld, and
B Beer, and
I Thum, and
W Kraft
March 1992,
AIDS (London, England),
G Hoffmann-Fezer, and
W Mortelbauer, and
K Hartmann, and
J Mysliwietz, and
S Thefeld, and
B Beer, and
I Thum, and
W Kraft
July 1997,
Veterinary immunology and immunopathology,
G Hoffmann-Fezer, and
W Mortelbauer, and
K Hartmann, and
J Mysliwietz, and
S Thefeld, and
B Beer, and
I Thum, and
W Kraft
November 1991,
Journal of the American Veterinary Medical Association,
G Hoffmann-Fezer, and
W Mortelbauer, and
K Hartmann, and
J Mysliwietz, and
S Thefeld, and
B Beer, and
I Thum, and
W Kraft
July 2022,
The Veterinary record,
G Hoffmann-Fezer, and
W Mortelbauer, and
K Hartmann, and
J Mysliwietz, and
S Thefeld, and
B Beer, and
I Thum, and
W Kraft
April 1994,
Immunology,
